Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,559 | -7,805 | -5,633 | -3,757 | -1,747 |
| Depreciation Amortization | 20 | 43 | 28 | 23 | 19 |
| Accounts receivable | 27 | 40 | -49 | -11 | -59 |
| Other Working Capital | 296 | 548 | 260 | -83 | -380 |
| Other Operating Activity | 92 | 727 | 718 | 547 | 253 |
| Operating Cash Flow | $-1,124 | $-6,448 | $-4,677 | $-3,281 | $-1,915 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -88 | -179 | -6 | -6 |
| Investing Cash Flow | $N/A | $-88 | $-179 | $-6 | $-6 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,000 | 3,000 | 2,216 | 1,051 | 51 |
| Common Stock Issued | N/A | 1,500 | 1,500 | 500 | 500 |
| Other Financing Activity | 48 | 1,867 | 1,343 | 1,652 | 1,528 |
| Financing Cash Flow | $1,048 | $6,367 | $5,060 | $3,203 | $2,078 |
| Beginning Cash Position | 132 | 302 | 302 | 302 | 302 |
| End Cash Position | 56 | 132 | 505 | 217 | 459 |
| Net Cash Flow | $-76 | $-170 | $204 | $-85 | $158 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,124 | -6,448 | -4,677 | -3,281 | -1,915 |
| Capital Expenditure | N/A | -88 | -179 | -6 | -6 |
| Free Cash Flow | -1,124 | -6,537 | -4,856 | -3,288 | -1,921 |